BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 04, 2010
 |  BC Week In Review  |  Company News  |  Deals

Artes Biotechnology GmbH, Select Vaccines deal

Artes acquired Anavax virus-like particle (VLP) technology from Select Vaccines for an undisclosed upfront payment. Anavax also is eligible...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >